United States

People: Pfizer Inc (PFE)

PFE on New York Consolidated

23 Jun 2017
Change (% chg)

$0.11 (+0.32%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Read, Ian 

Mr. Ian C. Read is Chairman of the Board, Chief Executive Officer of the Company. He is Chairman of the Board and Chief Executive Officer of Pfizer since December 2011. President and Chief Executive Officer from December 2010. Previously, he served as Senior Vice President and Group President of the Worldwide Biopharmaceutical Businesses, which he led from 2006 through December 2010. In that role, he oversaw five global business units—Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets. Mr. Read began his career with Pfizer in 1978 as an operational auditor. He worked in Latin America through 1995, holding positions including Chief Financial Officer, Pfizer Mexico, and Country Manager, Pfizer Brazil. In 1996, he was appointed President of Pfizer’s International Pharmaceuticals Group, with responsibility for Latin America and Canada. He became Executive Vice President, Europe, in 2000, was named a Corporate Vice President in 2001, and assumed responsibility for Canada, in addition to Europe, in 2002. Mr. Read later became accountable for operations in both the Africa/Middle East region and Latin America as well. Director of Kimberly-Clark Corporation. Mr. Read also serves on the Boards of Pharmaceutical Research and Manufacturers of America (PhRMA), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the Partnership of New York City.

Basic Compensation

Total Annual Compensation, USD 5,905,250
Restricted Stock Awards, USD 3,984,590
Long-Term Incentive Plans, USD --
All Other, USD 7,431,630
Fiscal Year Total, USD 17,321,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ian Read


Frank D'Amelio


Albert Bourla


Mikael Dolsten


John Young


Rady Johnson

As Of  30 Dec 2016